Melatonin: Can it stop the ringing?

Agnes Hurtuk, Claudia Dome, Christopher H. Holloman, Kelly Wolfe, D. Bradley Welling, Edward E. Dodson, Abraham Jacob

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objectives: We sought to report the efficacy of oral melatonin as treatment for chronic tinnitus and to determine whether particular subsets of tinnitus patients have greater benefit from melatonin therapy than others. Methods: This was a prospective, randomized, double-blind, crossover clinical trial in an ambulatory tertiary referral otology and neurotology practice. Adults with chronic tinnitus were randomized to 3 mg melatonin or placebo nightly for 30 days followed by a 1-month washout period. Each group then crossed into the opposite treatment arm for 30 days. The tests audiometric tinnitus matching (TM), Tinnitus Severity Index (TSI), Self Rated Tinnitus (SRT), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Inventory (BDI) were administered at the outset and every 30 days thereafter to assess the effects of each intervention. Results: A total of 61 subjects completed the study. A significantly greater decrease in TM and SRT scores (p < 0.05) from baseline was observed after treatment with melatonin relative to the effect observed with placebo. Male gender, bilateral tinnitus, noise exposure, no prior tinnitus treatment, absence of depression and/or anxiety at baseline, and greater pretreatment TSI scores were associated with a positive response to melatonin. Absence of depression and/or anxiety at baseline, greater pretreatment TSI scores, and greater pretreatment SRT scores were found to be positively associated with greater likelihood of improvement in both tinnitus and sleep with use of melatonin (p < 0.05). Conclusions: Melatonin is associated with a statistically significant decrease in tinnitus intensity and improved sleep quality in patients with chronic tinnitus. Melatonin is most effective in men, those without a history of depression, those who have not undergone prior tinnitus treatments, those with more severe and bilateral tinnitus, and those with a history of noise exposure.

Original languageEnglish (US)
Pages (from-to)433-440
Number of pages8
JournalAnnals of Otology, Rhinology and Laryngology
Volume120
Issue number7
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Tinnitus
Melatonin
Ego
Depression
Sleep
Noise
Therapeutics
Anxiety
Neurotology
Placebos
Otolaryngology

Keywords

  • Melatonin
  • Tinnitus

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Hurtuk, A., Dome, C., Holloman, C. H., Wolfe, K., Welling, D. B., Dodson, E. E., & Jacob, A. (2011). Melatonin: Can it stop the ringing? Annals of Otology, Rhinology and Laryngology, 120(7), 433-440.

Melatonin : Can it stop the ringing? / Hurtuk, Agnes; Dome, Claudia; Holloman, Christopher H.; Wolfe, Kelly; Welling, D. Bradley; Dodson, Edward E.; Jacob, Abraham.

In: Annals of Otology, Rhinology and Laryngology, Vol. 120, No. 7, 07.2011, p. 433-440.

Research output: Contribution to journalArticle

Hurtuk, A, Dome, C, Holloman, CH, Wolfe, K, Welling, DB, Dodson, EE & Jacob, A 2011, 'Melatonin: Can it stop the ringing?', Annals of Otology, Rhinology and Laryngology, vol. 120, no. 7, pp. 433-440.
Hurtuk A, Dome C, Holloman CH, Wolfe K, Welling DB, Dodson EE et al. Melatonin: Can it stop the ringing? Annals of Otology, Rhinology and Laryngology. 2011 Jul;120(7):433-440.
Hurtuk, Agnes ; Dome, Claudia ; Holloman, Christopher H. ; Wolfe, Kelly ; Welling, D. Bradley ; Dodson, Edward E. ; Jacob, Abraham. / Melatonin : Can it stop the ringing?. In: Annals of Otology, Rhinology and Laryngology. 2011 ; Vol. 120, No. 7. pp. 433-440.
@article{4ce3e67a9f1a40a4946306d6e0bce34e,
title = "Melatonin: Can it stop the ringing?",
abstract = "Objectives: We sought to report the efficacy of oral melatonin as treatment for chronic tinnitus and to determine whether particular subsets of tinnitus patients have greater benefit from melatonin therapy than others. Methods: This was a prospective, randomized, double-blind, crossover clinical trial in an ambulatory tertiary referral otology and neurotology practice. Adults with chronic tinnitus were randomized to 3 mg melatonin or placebo nightly for 30 days followed by a 1-month washout period. Each group then crossed into the opposite treatment arm for 30 days. The tests audiometric tinnitus matching (TM), Tinnitus Severity Index (TSI), Self Rated Tinnitus (SRT), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Inventory (BDI) were administered at the outset and every 30 days thereafter to assess the effects of each intervention. Results: A total of 61 subjects completed the study. A significantly greater decrease in TM and SRT scores (p < 0.05) from baseline was observed after treatment with melatonin relative to the effect observed with placebo. Male gender, bilateral tinnitus, noise exposure, no prior tinnitus treatment, absence of depression and/or anxiety at baseline, and greater pretreatment TSI scores were associated with a positive response to melatonin. Absence of depression and/or anxiety at baseline, greater pretreatment TSI scores, and greater pretreatment SRT scores were found to be positively associated with greater likelihood of improvement in both tinnitus and sleep with use of melatonin (p < 0.05). Conclusions: Melatonin is associated with a statistically significant decrease in tinnitus intensity and improved sleep quality in patients with chronic tinnitus. Melatonin is most effective in men, those without a history of depression, those who have not undergone prior tinnitus treatments, those with more severe and bilateral tinnitus, and those with a history of noise exposure.",
keywords = "Melatonin, Tinnitus",
author = "Agnes Hurtuk and Claudia Dome and Holloman, {Christopher H.} and Kelly Wolfe and Welling, {D. Bradley} and Dodson, {Edward E.} and Abraham Jacob",
year = "2011",
month = "7",
language = "English (US)",
volume = "120",
pages = "433--440",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "7",

}

TY - JOUR

T1 - Melatonin

T2 - Can it stop the ringing?

AU - Hurtuk, Agnes

AU - Dome, Claudia

AU - Holloman, Christopher H.

AU - Wolfe, Kelly

AU - Welling, D. Bradley

AU - Dodson, Edward E.

AU - Jacob, Abraham

PY - 2011/7

Y1 - 2011/7

N2 - Objectives: We sought to report the efficacy of oral melatonin as treatment for chronic tinnitus and to determine whether particular subsets of tinnitus patients have greater benefit from melatonin therapy than others. Methods: This was a prospective, randomized, double-blind, crossover clinical trial in an ambulatory tertiary referral otology and neurotology practice. Adults with chronic tinnitus were randomized to 3 mg melatonin or placebo nightly for 30 days followed by a 1-month washout period. Each group then crossed into the opposite treatment arm for 30 days. The tests audiometric tinnitus matching (TM), Tinnitus Severity Index (TSI), Self Rated Tinnitus (SRT), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Inventory (BDI) were administered at the outset and every 30 days thereafter to assess the effects of each intervention. Results: A total of 61 subjects completed the study. A significantly greater decrease in TM and SRT scores (p < 0.05) from baseline was observed after treatment with melatonin relative to the effect observed with placebo. Male gender, bilateral tinnitus, noise exposure, no prior tinnitus treatment, absence of depression and/or anxiety at baseline, and greater pretreatment TSI scores were associated with a positive response to melatonin. Absence of depression and/or anxiety at baseline, greater pretreatment TSI scores, and greater pretreatment SRT scores were found to be positively associated with greater likelihood of improvement in both tinnitus and sleep with use of melatonin (p < 0.05). Conclusions: Melatonin is associated with a statistically significant decrease in tinnitus intensity and improved sleep quality in patients with chronic tinnitus. Melatonin is most effective in men, those without a history of depression, those who have not undergone prior tinnitus treatments, those with more severe and bilateral tinnitus, and those with a history of noise exposure.

AB - Objectives: We sought to report the efficacy of oral melatonin as treatment for chronic tinnitus and to determine whether particular subsets of tinnitus patients have greater benefit from melatonin therapy than others. Methods: This was a prospective, randomized, double-blind, crossover clinical trial in an ambulatory tertiary referral otology and neurotology practice. Adults with chronic tinnitus were randomized to 3 mg melatonin or placebo nightly for 30 days followed by a 1-month washout period. Each group then crossed into the opposite treatment arm for 30 days. The tests audiometric tinnitus matching (TM), Tinnitus Severity Index (TSI), Self Rated Tinnitus (SRT), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Inventory (BDI) were administered at the outset and every 30 days thereafter to assess the effects of each intervention. Results: A total of 61 subjects completed the study. A significantly greater decrease in TM and SRT scores (p < 0.05) from baseline was observed after treatment with melatonin relative to the effect observed with placebo. Male gender, bilateral tinnitus, noise exposure, no prior tinnitus treatment, absence of depression and/or anxiety at baseline, and greater pretreatment TSI scores were associated with a positive response to melatonin. Absence of depression and/or anxiety at baseline, greater pretreatment TSI scores, and greater pretreatment SRT scores were found to be positively associated with greater likelihood of improvement in both tinnitus and sleep with use of melatonin (p < 0.05). Conclusions: Melatonin is associated with a statistically significant decrease in tinnitus intensity and improved sleep quality in patients with chronic tinnitus. Melatonin is most effective in men, those without a history of depression, those who have not undergone prior tinnitus treatments, those with more severe and bilateral tinnitus, and those with a history of noise exposure.

KW - Melatonin

KW - Tinnitus

UR - http://www.scopus.com/inward/record.url?scp=79960177515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960177515&partnerID=8YFLogxK

M3 - Article

C2 - 21859051

AN - SCOPUS:79960177515

VL - 120

SP - 433

EP - 440

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 7

ER -